Israel on Monday, the Pfizer/BioNTech . said COVID-19 vaccine was still highly effective in preventing serious illness, while also reporting a decrease in the incidence of infections and symptomatic illness. The observation coincided with the end of social distancing requirements and the spread of a new Delta variant.
Vaccine effectiveness to prevent infection and symptomatic disease has fallen to 64% since June 6. Ministry of Health said:, Reuters reported. The good news is that the vaccine was 93% effective in preventing serious illness from the coronavirus, including hospitalizations.
MYOCARDITIS AFTER COVID-19 VACCINATION HIGHER IN MILITARY POPULATION THAN EXPECTED, STUDY FINDS
The Delta variant is estimated to spread 40-60% faster than the Alpha variant that dominated the US by April, which itself was about 50% more transmissible than the original strain.
Fox News has contacted Pfizer but has not heard back.
The ministry did not disclose the previous level of effectiveness against infections before the decline. In May, it released a report saying two doses of the Pfizer vaccine were more than 95% effective against infections, hospitalizations and serious illness, according to the news agency.
About 60% of the Israeli population has received at least one shot of the Pfizer vaccine. The country then saw a drop in coronavirus cases from over 100,000 in January to single numbers in June.
CLICK HERE TO GET THE FOX NEWS APP
Since the end of social distancing and mask requirements, the country has seen the number of cases rise, to 343 on Sunday.